| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 720147 | Null | 0.0112425217758227 | 0.045593489 |
| NSC 720194 | Null | 0.0112425217758227 | 0.099965731 |
| NSC 728037 | 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline | 0.0112425217758227 | 0.36083523 |
| NSC 747174 | Null | 0.0112425217758227 | 0.17701002 |
| NSC 756169 | GSK317314A | 0.0112425217758227 | 0.42043813 |
| NSC 763186 | Null | 0.0112425217758227 | 0.71688841 |
| NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0114553853234976 | 0.2788283 |
| NSC 166382 | Null | 0.0114553853234976 | 0.09036952 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0114553853234976 | 0.41643897 |
| NSC 185065 | Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- | 0.0114553853234976 | 0.24949479 |